로딩 중…
지수 로딩 중…
Niagen Bioscience Inc
NAGE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$3.50+3.86%
2026-06-18
Price Chart
Niagen Bioscience Inc-74.60%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $279M |
| Revenue | $130M |
| Net Income | $19M |
| Total Assets | $114M |
| Net Assets | $82M |
| Value | |
| P/E | 14.96x |
| P/B | 3.39x |
| PEG | 0.60x |
| P/S | 2.14x |
| EV/EBITDA | 16.07x |
| FCF Yield | 1.45% |
| Profitability | |
| ROE | 22.64% |
| ROA | 16.30% |
| Op. Margin | 8.51% |
| Revenue Growth | 3.26% |
| Earnings Growth | 24.79% |
| Financial Health | |
| Debt Ratio | 38.87% |
| Total Debt | $3M |
| FCF | $4M |
| Cash | $67M |
| Current Ratio | 4.61x |
| Net Debt/EBITDA | -4.79x |
| Performance | |
| 1Y Return | -74.60% |
| 1M Return | -4.63% |
| From 52W High | -76.17% |
| 1Y MDD | -76.61% |
| Trading | |
| Volume | 883,842 shares |
| Trading Value | $3M |
| Per Share | |
| EPS | $0.22 |
| BPS | $0.97 |